surmount-1 trial tirzepatide non-diabetic weight loss obesity without diabetes non- diabetic once weekly for the treatment of in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 SURMOUNT-1: Tirzepatide Drastically Tirzepatide once weekly for the

What makes BPC-157 unique is its ability to aid in healing soft tissues, tendons, ligaments, and even the gut lining

The degree of interference appears to be dose-dependent, meaning higher doses of either mineral create more significant competition

RX: Semaglutide and Tirzepatide Recently approved by the FDA, Semaglutide, also known as Ozempic or Wegovy, is a weekly weight loss injection obtained by prescription

By using fats as energy for muscle contractions, the body is sparing glycogen and also delaying the accumulation of lactic acid in muscles

Compounded drugs: Questions and answers

A landmark study in PNAS showed that Akkermansia interacts directly with the intestinal epithelium and that, in mice, administering it reversed key features of diet-induced obesity, including fat mass gain, metabolic inflammation, and gut barrier disruption (Everard et al., 2013)